Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “LTD.”

1,301 pharma patents match "LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,301
Index total 30,257
Page 11 / 55

Quick answer

This filtered view shows 1,301 pharmaceutical patents matching "LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,301 results for “LTD.” · 30,257 patents in full index Clear search

  1. US 11045466

    Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same

    Platform Brightworks Two, Ltd. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  2. US 11045453

    Serine protease inhibitor for treating coronavirus infection

    RedHill Biopharma Ltd. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  3. US 11046701

    Salt of cetagliptin, preparation method thereof, pharmaceutical composition, and use thereof

    CGeneTech (Suzhou, China) CO., Ltd. · Granted Jun 29, 2021 · Expires Jun 24, 2041

    granted
  4. US 11040084

    Stable antibody-drug conjugate, preparation method therefor, and use thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  5. US 11040125

    Neurotrophic factor carrier, method for producing the same, and method for regenerating a nerve using the same

    Wiregene Co., Ltd. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted
  6. US 11028369

    Induced extended pluripotent stem cells, method of making and using

    BeiHao Stem Cell and Regenerative Medicine Research Institute Co., Ltd. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  7. US 11026988

    Traditional Chinese medicine composition and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Jun 8, 2021 · Expires Jun 3, 2041

    granted
  8. US 11020326

    Hollow particles and cosmetic

    JGC Catalysts and Chemicals Ltd. · Granted Jun 1, 2021 · Expires May 27, 2041

    granted
  9. US 11008622

    Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereof

    Wellmarker Bio Co., LTD. · Granted May 18, 2021 · Expires May 13, 2041

    granted
  10. US 11000562

    Use of isolated fractions of mastic gum for treating optic neuropathy

    REGENERA PHARMA LTD. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  11. US 10993948

    RNA polymerase I inhibitors and uses thereof

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted May 4, 2021 · Expires Apr 29, 2041

    granted
  12. US 10987354

    Inhibitors of influenza virus replication and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  13. US 10987336

    Method of preventing or treating side effect of tumor therapy

    ONQUALITY PHARMACEUTICALS CHINA LTD. · Granted Apr 27, 2021 · Expires Apr 22, 2041

    granted
  14. US 10981902

    5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor

    Merck MSD (R&D) China Co., LTD. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  15. US 10980780

    Methods and compositions of anti-inflammatory drug and dicer activator for treatment of neuronal diseases

    NEUROSENSE THERAPEUTICS LTD. · Granted Apr 20, 2021 · Expires Apr 15, 2041

    granted
  16. US 10973758

    Methods of eye treatment using therapeutic compositions containing dipyridamole

    O.D. Ocular Discovery Ltd. · Granted Apr 13, 2021 · Expires Apr 8, 2041

    granted
  17. US 10967017

    Traditional Chinese medicine composition and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  18. US 10967051

    Methods and compositions for treating NAFLD, hepatic steatosis, and sequelae thereof

    Oramed Ltd. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  19. US 10968495

    Lactobacillus reuteri and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  20. US 10967016

    Traditional Chinese medicine composition and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  21. US 10966970

    Fused tricyclic compounds and uses thereof in medicine

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Apr 6, 2021 · Expires Apr 1, 2041

    granted
  22. US 10960039

    Composition, preparation method and use of the same in manufacture of a product for relieving thyroid nodules

    INFINITUS (CHINA) COMPANY LTD. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  23. US 10960044

    Powder formulation having hypoglycemic and hypolipidemic functions and method for preparing the same

    INFINITUS (CHINA) COMPANY LTD. · Granted Mar 30, 2021 · Expires Mar 25, 2041

    granted
  24. US 10946000

    Method for treating cancer with combination therapy

    RedHill Biopharma Ltd. · Granted Mar 16, 2021 · Expires Mar 11, 2041

    granted